Journal of Ocular Pharmacology and Therapeutics
Published by Mary Ann Liebert
ISSN : 1080-7683 eISSN : 1557-7732
Abbreviation : J. Ocul. Pharmacol. Ther.
Aims & Scope
Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders.
The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.
Journal of Ocular Pharmacology and Therapeutics coverage includes: Glaucoma Cataracts Retinal degeneration Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Ocular inflammatory and immune disorders Gene and cell-based therapies Ocular metabolic disorders Ocular ischemia and blood flow Proliferative disorders of the eye Eyes on Drug Discovery - written by Gary D.
Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.1 |
2024 | 1.90 |
Journal Rank
Year | Value |
---|---|
2024 | 9727 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 482 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.597 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 76 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Citation: 384
Authors: VINCENT H.L., JOSEPH R.
-
Trabeculectomy with Simultaneous Topical Application of Mitomycin-C in Refractory Glaucoma
Citation: 338
Authors: CHEN-WU, HO-TUNG, JIA-SHIN, CHIOU-CHORN
-
Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical Trials
Citation: 230
Authors: Joshua Seth, Paul E., Mark J., Christopher J.
-
Effects of Different Concentrations of Atropine on Controlling Myopia in Myopic Children
Citation: 208
Authors: YUNG-FENG, CHIEN-HSIUNG, AI-CHUAN, TZYY-CHANG, LUKE L.-K., POR-TYING
-
Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative Study
Citation: 158
Authors: Sarah A., Sharon M., Richard P.
-
Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Citation: 154
Authors: Cheng-Wen, Bryan, Lori A., Carmen L., Da-Wen, Padmanabhan P., Ponugoti Vasantha, Mitchell A., Casey C.
-
Novel Strategies for Anterior Segment Ocular Drug Delivery
Citation: 153
Authors: Kishore, Sulabh P., Aswani Dutt, Ashim K.